---
created: 2025-04-13
updated: 2025-04-13T10:53
id: iEVub[Z`eE
specialty: pharmaco
specialty_id: 469
tags:
  - source/ak-original-decks::step-1::lolnotacop::drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::11-antitumor-antibiotics
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::11-antitumor-antibiotics::bleomycin
  - "source/ak-step1-v11:": 
  - theme/ome::06-inflammation-neoplasia::08-cycle-chemo
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/pixorize::02-biochem::22-onc-drugs::20-bleomycin
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::11-oncology::bleomycin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::02-dna-&-cellular-division::03-bleomycin,-doxorubicin,-daunorubicin,-actinomycin-d
  - "source/ak-step1-v11:": 
  - theme/uworld::10000-99999::14000-14999::14848"
type: flashcard
---

# Question
Bleomycin has a(n) **DNA** binding region and a(n) **iron** binding region

---

# Answer
chelates metal ions and produces a reaction that forms free radicals == creates breaks in DNA